Cargando…
What happens when we treat the “Typhoid Mary” of COVID‐19
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was declared a pandemic on 11 March 2020. We have since seen its fast spread worldwide. A likely contributing factor was the lack of symptoms of some of the carriers, making them unaware of their risk of spreading to other more v...
Autores principales: | Ng, Boon Hau, Nik Abeed, Nik Nuratiqah, Abdul Hamid, Mohamed Faisal, Soo, Chun Ian, Low, Hsueh Jing, Ban, Yu‐Lin Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316583/ https://www.ncbi.nlm.nih.gov/pubmed/32607242 http://dx.doi.org/10.1002/rcr2.604 |
Ejemplares similares
-
Resolution of refractory chylothorax with a combination of talc pleurodesis and CPAP
por: Ng, Boon Hau, et al.
Publicado: (2020) -
Indwelling pleural catheter and successful autopleurodesis of refractory inflammatory lupus effusion
por: Ng, Boon Hau, et al.
Publicado: (2020) -
The benefit of indwelling pleural catheter with ambulatory pneumothorax device and autologous blood patch pleurodesis in lymphangioleiomyomatosis with persistent air leak
por: Ng, Boon Hau, et al.
Publicado: (2023) -
Organising pneumonia manifesting as a late-phase complication of COVID-19
por: Ng, Boon Hau, et al.
Publicado: (2021) -
Hydrofluorocarbons pneumonitis as a complication of inhalation injury following air‐conditioning repairs
por: Abdul Malik, Afifah Aqilah, et al.
Publicado: (2022)